Claimed effect · Dihexa

Does Dihexa help with cognition / synapse formation?

D
Grade D — no human evidence0 controlled · effect size: not measurable
Short answerNo human evidence. As of 3 September 2026, no controlled human trial has tested Dihexa for cognition / synapse formation. Dihexa promotes synaptogenesis and improves memory in rodent models, including models of Alzheimer's and Parkinson's disease. No human trial has tested it.

What the studies show

Dihexa promotes synaptogenesis and improves memory in rodent models, including models of Alzheimer's and Parkinson's disease. No human trial has tested it.

Animal studies, cell studies, or anecdotes only. This is where almost every viral peptide sits. Promising and proven are different words for a reason.

In context

Dihexa is a small synthetic molecule derived from angiotensin IV, studied for its striking ability to promote new synapse formation in rodents and its potential in memory and Parkinson's models. It is not a true peptide and, more importantly, has never been tested in a controlled human trial. It is sold as a 'nootropic' research chemical with no human evidence and no safety data.

Dihexa is not approved. Legal status differs by country — see the regulation section or the jurisdiction pages.

Questions

Is Dihexa proven to help with cognition / synapse formation?
No. There is no human evidence for it (0 controlled); the claim rests on animal or cell studies and LYO grades it D.
What studies are behind the grade?
Dihexa promotes synaptogenesis and improves memory in rodent models, including models of Alzheimer's and Parkinson's disease. No human trial has tested it.
Is Dihexa approved for this?
No. Dihexa is not approved; it is not an approved medicine for any indication in the jurisdictions LYO covers.

Other outcomes for Dihexa

Written and maintained by LYO Research — how pages are written and checked. Reviewed 3 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →